Correlation Between Orexo AB and Oncopeptides

Can any of the company-specific risk be diversified away by investing in both Orexo AB and Oncopeptides at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Orexo AB and Oncopeptides into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Orexo AB and Oncopeptides AB, you can compare the effects of market volatilities on Orexo AB and Oncopeptides and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Orexo AB with a short position of Oncopeptides. Check out your portfolio center. Please also check ongoing floating volatility patterns of Orexo AB and Oncopeptides.

Diversification Opportunities for Orexo AB and Oncopeptides

-0.1

Correlation Coefficient

Orexo AB  Oncopeptides

Good diversification

The 3 months correlation between Orexo and Oncopeptides is -0.1. Overlapping area represents the amount of risk that can be diversified away by holding Orexo AB and Oncopeptides AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Oncopeptides AB and Orexo AB is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Orexo AB are associated (or correlated) with Oncopeptides. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Oncopeptides AB has no effect on the direction of Orexo AB i.e., Orexo AB and Oncopeptides go up and down completely randomly.

Pair Corralation between Orexo AB and Oncopeptides

Assuming the 90 days trading horizon Orexo AB is expected to generate 1.09 times more return on investment than Oncopeptides. However, Orexo AB is 1.09 times more volatile than Oncopeptides AB. It trades about 0.04 of its potential returns per unit of risk. Oncopeptides AB is currently generating about -0.09 per unit of risk. If you would invest  1,646  in Orexo AB on September 24, 2024 and sell it today you would earn a total of  280.00  from holding Orexo AB or generate 17.01% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Orexo AB  vs.  Oncopeptides AB

Orexo AB

Risk-Adjusted Performance

9 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Orexo AB are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Orexo AB unveiled solid returns over the last few months and may actually be approaching a breakup point.

Oncopeptides AB

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Oncopeptides AB has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Pair Trading with Orexo AB and Oncopeptides

The main advantage of trading using opposite Orexo AB and Oncopeptides positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Orexo AB position performs unexpectedly, Oncopeptides can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Oncopeptides will offset losses from the drop in Oncopeptides' long position.

The idea behind Orexo AB and Oncopeptides AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.